nVerses Capital LLC Has $1.02 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

nVerses Capital LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,500 shares of the company’s stock after purchasing an additional 700 shares during the quarter. nVerses Capital LLC’s holdings in HCA Healthcare were worth $1,016,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of HCA. Bangor Savings Bank lifted its position in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare in the second quarter valued at about $28,000. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Wells Fargo & Company raised their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. UBS Group increased their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $365.65.

HCA Healthcare Trading Down 0.3 %

Shares of HCA Healthcare stock traded down $1.25 during trading on Thursday, hitting $407.98. The company’s stock had a trading volume of 141,512 shares, compared to its average volume of 1,135,407. The stock has a market cap of $106.86 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $416.72. The stock has a 50-day moving average price of $390.17 and a two-hundred day moving average price of $349.03. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the prior year, the firm posted $4.29 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.